Dr. Karp is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161Fax+1 713-745-6982
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1978 - 1979
Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalFellowship, Hematology and Medical Oncology, 1976 - 1978- Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalResidency, Internal Medicine, 1973 - 1976
Duke University School of MedicineClass of 1973
Certifications & Licensure
FL State Medical License 2021 - Present
MA State Medical License 1978 - 2025
TX State Medical License 2004 - 2025
OK State Medical License 2020 - 2021
ME State Medical License Active through 1992- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Clinical Trials
- Aspirin in Treating Patients With Colorectal Cancer That Has Been Surgically Removed Start of enrollment: 1993 May 01
- S0000 Selenium and Vitamin E in Preventing Prostate Cancer Start of enrollment: 2001 Jul 01
- Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer Start of enrollment: 2000 Dec 18
- Join now to see all
Publications & Presentations
PubMed
- Learning From Mistakes: Navigating Medical Errors in Oncology From Prevention to Management.Daniel D Karp, Jessica A Osburn, Mohamed A Gouda
Journal of Immunotherapy and Precision Oncology. 2024-11-01 - Genomic Alterations in DNA Mismatch Repair Genes Across Different Cancer Types.Vijaykumar R Holla, Michael P Kahle, Sun-Hee Kim, Arash Ronaghy, Richard K Yang
JCO Precision Oncology. 2024-11-01 - Phase I/II study of BMS-986156 with ipilimumab or nivolumab with or without stereotactic ablative radiotherapy in patients with advanced solid malignancies.Joe Y Chang, Xinyan Xu, Girish S Shroff, Nathan I Comeaux, Wei Li
Journal for Immunotherapy of Cancer. 2024-10-09
Press Mentions
NIH Funding Spurs Expansion of Clinical and Translational Research in TexasAugust 7th, 2019
Grant Support
- Clinical And TranslationalNational Cancer Institute2008–2011
- Eastern Cooperative Oncology GroupNational Cancer Institute1999–2001
- Eastern Cooperative Oncology GroupNational Cancer Institute1996
- Phase I Trial Interleukin 1 Alpha And Cyclophosphamide In Solid TumorsNational Center For Research Resources1995–1996
- Eastern Cooperative Oncology GroupNational Cancer Institute1991–1995
- OncologyNational Cancer Institute1994
- Primary Breast Cancer Therapy Group-NsabpNational Cancer Institute1991
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
